21 September, 2021 by The TZ Newswire Staff Comments Off on Luckin Coffee Enters into Binding Term Sheet to Settle U.S. Securities Class Action
Luckin Coffee Enters into Binding Term Sheet to Settle U.S. Securities Class Action
BEIJING, Sept. 21, 2021 (GLOBE NEWSWIRE) — Luckin Coffee Inc. (in Provisional Liquidation) (“Luckin Coffee” or the “Company”) (OTC: LKNCY) today announced that it has entered into a binding term sheet (the “Term Sheet”) with the Lead Plaintiffs in the provisionally certified class action In re Luckin Coffee Inc.
21 September, 2021 by The TZ Newswire Staff Comments Off on Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference
Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the 11th annual Partnership Opportunities in Drug Delivery (PODD) Conference, October 28-29, 2021 in Boston.
21 September, 2021 by The TZ Newswire Staff Comments Off on NFI schedules third quarter 2021 financial results release and conference call
NFI schedules third quarter 2021 financial results release and conference call
WINNIPEG, Manitoba, Sept. 21, 2021 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, today announced that it intends to release its third quarter 2021 financial results on Wednesday, November 3, 2021 prior to market open.
21 September, 2021 by The TZ Newswire Staff Comments Off on Pacira Announces Publication of Phase 3 Study of EXPAREL Infiltration in Pediatric Patients Undergoing Spinal or Cardiac Surgeries
Pacira Announces Publication of Phase 3 Study of EXPAREL Infiltration in Pediatric Patients Undergoing Spinal or Cardiac Surgeries
Study demonstrating safety and tolerability of EXPAREL published in Journal of Clinical Anesthesia Study demonstrating safety and tolerability of EXPAREL published in Journal of Clinical Anesthesia
21 September, 2021 by The TZ Newswire Staff Comments Off on Arbutus Appoints Lisa M. Caperelli as Vice President, Investor Relations
Arbutus Appoints Lisa M. Caperelli as Vice President, Investor Relations
WARMINSTER, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection, as well as therapies to treat coronaviruses (including COVID-19), today announced the Company has appointed Lisa M.
21 September, 2021 by The TZ Newswire Staff Comments Off on Offer update – close of early bird discount
Offer update – close of early bird discount
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.
21 September, 2021 by The TZ Newswire Staff Comments Off on Senator Warren gets MakerDAO mixed up with failed 2016 project
Senator Warren gets MakerDAO mixed up with failed 2016 project
The office of Senator Elizabeth Warren, a famed foe of cryptocurrency, got MakerDAO mixed up with a failed experiment in decentralized autonomous organizations back in 2016. MakerDAO is among the top 10 DeFi protocols.